In the past, our working group has already reported on the difficulties of a patient-oriented and successful therapeutic approach to PASC. This can be explained, among other things, by non-specific inflammatory processes and mitochondrial dysfunctions in the musculature, which are not adequately addressed by conventional therapy options. The importance of myoreflex therapy in this context has been outlined in two recent publications as well as at previous congresses. To date, however, no work has been presented in which the positive effects of myoreflex therapy have been presented in comparison to a therapist's simultaneous prolonged attention without effective application of the myoreflex method ("apparent therapy") and in comparison to a genuine placebo group ("no therapy"). To close this gap, the current study was conducted under these study conditions.
Despite rapid advances in conventional medicine, chronic pain conditions, mental illnesses, and post-viral syndromes such as PASC are often difficult to treat satisfactorily. New, highly individualized treatment approaches are therefore needed to alleviate and, ideally, even cure the symptoms that affect everyday life. Myoreflextherapy is a novel therapeutic method that has been developed since the early 1980s based on various findings and scientific disciplines, but has been described only sparsely in the international literature to date. This conference paper aims to provide an overview of the findings to date and to classify the therapy within the current therapeutic landscape.
